Pharmacells Ltd. has announced that our stem cell banking service, Oristem® which allows adults of any age to store these vital cells ready to treat diseases that they may get later in life, is now available in 6 countries around the globe.
Since the launch of the product in 2011, we have expanded reach to Hong Kong, China, Lebanon, Pakistan, Ireland and the USA with negotiations underway in several other countries.
To celebrate our global roll out, we have cut our UK price by one third to £1999 including VAT until the end of 2012 only. This is a one-time only offer and subject to a maximum of 4 per household. It is our lowest ever price and will not be repeated.
Until the launch of Oristem®, it has only been possible to store cells using invasive, costly techniques - designed to access cell types that have already “chosen” pathways within the body.
The cell type stored using the Oristem® method is significantly less mature, which in scientific terms means that they have much more potential for use within personalized treatments, therapies or pharmaceuticals.
Unlike all other methods, the Oristem® product allows the client to choose when and where their blood is taken. They can then relax in the knowledge that their stem cells have been isolated and stored when they are young and healthy, ready to be returned to them at a time, should it arrive, when they need the cells again to treat a serious illness.
Speed to treatment is something that many have never considered but it is a major factor in cell therapy. Several studies have shown that if a donor receives their cells with 48 hours of a major trauma, the efficacy of that cell therapy is greatly improved.
That’s why we provide a “stem cell donor card” designed to be carried in the wallet or purse and there to educate medical professionals to the availability of stem cells in the event of a major health incident.
Stem cells are the building blocks of life and are essential for repair of damaged areas of the body.
Already stem cells are used in several routine treatments for a wide variety of medical concerns including leukaemia, lymphoma, blood disorders and eye cornea damage.
Every year billions are spent globally to push forward this amazing new area of science. Research into many health concerns including Alzheimer's, Parkinson's, Multiple Sclerosis, Diabetes and Stroke heralds the promise of a new dawn within Medical Science.
Athol Haas, CEO of Pharmacells, said “We have worked extremely hard over the last few years to bring this amazing new breakthrough technology to the market. We're proud to be able to use our patented technology to help ensure the future health of our clients. Stem cells are at the forefront of a new wave of medical technologies and our Oristem® product offers, for the first time, a cost effective opportunity for anyone to improve their future health and that of their families.”
To deliver Oristem®, Pharmacells commissioned our own clean room facility ensuring that every donor’s sample is processed to the highest possible standards. We hold a full license from the Human Tissue Authority, further demonstrating our commitment to excellence.
With stem cell research developing quickly and the number of new treatments and therapies expected to rise considerably over the coming years, having quick access to users own healthy cells is a wise health choice. After all, none of us is getting any younger!